Janux Therapeutics, Inc. (JANX) has a consensus analyst rating of Buy, based on 13 analysts covering the stock. Of those, 11 recommend buying, 2 recommend holding, and 0 recommend selling.
The analyst consensus price target for JANX is $39.80, representing a +161.2% upside from the current price of $15.24. Price targets range from a low of $29.00 to a high of $57.00.
